Tachyphylaxis with desmopressin
WebApr 26, 2024 · Stimate (Desmopressin Acetate Nasal Spray) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. ... The tendency toward tachyphylaxis (lessening of response) with repeated administration given more frequently than once every 48 hours ... WebNov 20, 2012 · Patients can develop tachyphylaxis to desmopressin, rendering this agent of limited utility with repeated use.[11,12] 2. Administration and Pharmacokinetics. Desmopressin can be given intranasally, intravenously, subcutaneously or orally. The usual antidiuretic dose is 10–20μg intranasally (with a bioavailability of 10–20% from this ...
Tachyphylaxis with desmopressin
Did you know?
WebAims: To study desmopressin response in hemophilia A patients who received repeated doses perioperatively and to determine extent and determinants of tachyphylaxis. … WebAnaphylaxis has been reported rarely with intravenous and intranasal desmopressin acetate, including isolated cases of fatal anaphylaxis with intravenous desmopressin acetate. It is …
WebMay 8, 2024 · Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic analog of vasopressin, aka antidiuretic hormone created in 1977 used in the treatment of a wide variety of medical conditions to include … WebMay be repeated once daily for 3 to 5 days. Beyond 5 days, tachyphylaxis renders it ineffective; Intravenous or subcutaneous: Intravenous: 0.3 mcg/kg (maximum 20 mcg) diluted in 50 mL of normal saline and infused over 20 to 30 minutes; Subcutaneous (not approved for use in the United States): 0.3 mcg/kg (maximum 20 mcg) subcutaneously; …
WebDesmopressin (1-deamino-8-d -arginine vasopressin (DDAVP)) is a synthetic analogue of the antidiuretic hormone 8-arginine vasopressin. DDAVP stimulates the vasopressin V2 receptor, which causes water retention and the release of FVIII and vWF from endothelium. DDAVP has been used in mild hemophilia and type I vWD (decreased multimers of vWF). WebDesmopressin. 423 Parenteral desmopressin was originally formulated at a concentration of 4 μg/mL, to be used at a 0.3-μg/kg/dose to treat bleeding diatheses such as hemophilia A and von Willebrand disease type 1. ... but tachyphylaxis may occur after three or four doses, 37 limiting further usefulness of DDAVP.
WebApr 4, 2024 · 1. Introduction [] Hyponatremia has a high prevalence in acute and chronic hospitalized patients and may lead to increased length of stay and higher financial burden[2–8] It is a marker of disease severity and is associated with increased mortality. []Syndrome of inappropriate antidiuresis (SIAD) is the most common cause of …
WebAnaphylaxis has been reported rarely with intravenous and intranasal desmopressin acetate, including isolated cases of fatal anaphylaxis with intravenous desmopressin acetate. It is not known whether antibodies to Desmopressin Acetate Injection 4 mcg/mL are produced after repeated injections. office state revenueWebSep 30, 2024 · Desmopressin Acetate is contraindicated in patients at increased risk of severe hyponatremia, such as patients with excessive fluid intake, illnesses that can cause fluid or electrolyte imbalances, and in those using loop diuretics or systemic or inhaled glucocorticoids [see Contraindications (4) and Warnings and Precautions (5.1) ] . office state revenue land taxWebSep 1, 2024 · Tachyphylaxis (lessening of response) with repeated administration (i.e., given more frequently than every 48 hours) may occur. The initial response is reproducible if DDAVP is administered every 2 to 3 … office startimes